Related Experiment Videos
Immunization with bacterial antigens: edwardsiellosis
R L Thune1, J P Hawke, D H Fernandez
1Department of Veterinary Science, Louisiana State University, Baton Rouge, USA.
Summary
Enteric septicaemia of catfish (ESC), caused by Edwardsiella ictaluri, is a significant disease. Current vaccines show limited protection, necessitating research into cell-mediated immunity for effective catfish disease control.
Area of Science:
- Aquatic Animal Health
- Fish Immunology
- Bacteriology
Background:
- Enteric septicaemia of catfish (ESC), caused by Edwardsiella ictaluri, is a major threat to commercial aquaculture in the United States.
- Edwardsiella ictaluri rapidly infects catfish, causing acute septicaemia within days, particularly at temperatures between 22-28°C.
- The pathogen exhibits immune evasion strategies, leading to systemic infections and significant mortality.
Purpose of the Study:
- To review the immunological challenges and vaccination strategies against Edwardsiella ictaluri in catfish.
- To identify key immunogenic antigens of Edwardsiella ictaluri.
- To propose future directions for developing effective catfish vaccines.
Main Methods:
- Analysis of Edwardsiella ictaluri antigens using SDS-PAGE and western blotting techniques.
- Review of existing vaccination studies utilizing purified components and killed whole cell preparations.
- Evaluation of antibody response and protection correlation in vaccinated catfish.
Main Results:
- Multiple immunogenic antigens were identified, with 34-37 KD and 60 KD proteins being consistently immunodominant.
- Vaccination with lipopolysaccharide or killed whole cells yielded equivocal results, with poor protection unless adjuvants were used.
- Antibody production did not always correlate with protection, requiring very high titres for efficacy.
Conclusions:
- Current vaccination approaches for Edwardsiella ictaluri have limitations in inducing protective immunity.
- The efficacy of existing vaccines may depend on environmental factors like temperature and booster exposures.
- Future vaccine development should focus on strategies that promote cell-mediated immunity against this facultative intracellular pathogen.